Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5244
Gene Symbol: ABCB4
ABCB4
0.020 GeneticVariation group BEFREE The ABCB4 transporter mediates phosphatidylcholine (PC) secretion at the canalicular membrane of hepatocytes and its genetic defects cause biliary diseases. 24723470 2014
Entrez Id: 5244
Gene Symbol: ABCB4
ABCB4
0.020 GeneticVariation group BEFREE Comparison of in silico prediction and experimental assessment of ABCB4 variants identified in patients with biliary diseases. 28587926 2017
Entrez Id: 64240
Gene Symbol: ABCG5
ABCG5
0.010 GeneticVariation group BEFREE We identify two new loci associated with GBD, GCKR rs1260326:T>C (P = 5.88 × 10(-7), ß = -0.146) and TTC39B rs686030:C>A (P = 6.95 x 10(-7), ß = 0.271) and detect four independent SNP effects in ABCG8 rs4953023:G>A (P=7.41 × 10(-47), ß = 0.734), ABCG8 rs4299376:G(>)T (P = 2.40 × 10(-18), ß = 0.278), ABCG5 rs6544718:T>C (P = 2.08 × 10(-14), ß = 0.044) and ABCG5 rs6720173:G>C (P = 3.81 × 10(-12), ß(=)0.262) in conditional analyses taking genotypes of rs4953023:G>A as a covariate. 25920552 2016
Entrez Id: 64241
Gene Symbol: ABCG8
ABCG8
0.010 GeneticVariation group BEFREE We identify two new loci associated with GBD, GCKR rs1260326:T>C (P = 5.88 × 10(-7), ß = -0.146) and TTC39B rs686030:C>A (P = 6.95 x 10(-7), ß = 0.271) and detect four independent SNP effects in ABCG8 rs4953023:G>A (P=7.41 × 10(-47), ß = 0.734), ABCG8 rs4299376:G(>)T (P = 2.40 × 10(-18), ß = 0.278), ABCG5 rs6544718:T>C (P = 2.08 × 10(-14), ß = 0.044) and ABCG5 rs6720173:G>C (P = 3.81 × 10(-12), ß(=)0.262) in conditional analyses taking genotypes of rs4953023:G>A as a covariate. 25920552 2016
Entrez Id: 335
Gene Symbol: APOA1
APOA1
0.020 Biomarker group LHGDN Ratio of Apo B/Apo A-I > or = 1 was inversely associated with risk of gallbladder disease (OR = 0.54, 95% CI = 0.37-0.80). 14567398 2004
Entrez Id: 335
Gene Symbol: APOA1
APOA1
0.020 Biomarker group BEFREE Restriction fragment length polymorphisms (RFLPs) of apolipoprotein B (XbaI, EcoRI), apolipoprotein A-I (PstI, MspI), and cholesteryl ester transfer protein (CETP) (EcoNI, TaqIA, TaqIB) genes were examined in a series of 210 cholecystectomy patients operated on for symptomatic gallbladder disease and in 92 healthy controls. 7616125 1995
Entrez Id: 338
Gene Symbol: APOB
APOB
0.030 GeneticVariation group BEFREE Restriction fragment length polymorphisms (RFLPs) of apolipoprotein B (XbaI, EcoRI), apolipoprotein A-I (PstI, MspI), and cholesteryl ester transfer protein (CETP) (EcoNI, TaqIA, TaqIB) genes were examined in a series of 210 cholecystectomy patients operated on for symptomatic gallbladder disease and in 92 healthy controls. 7616125 1995
Entrez Id: 338
Gene Symbol: APOB
APOB
0.030 GeneticVariation group BEFREE Apolipoprotein B (APOB) gene polymorphism in patients with gallbladder disease. 17350490 2007
Entrez Id: 338
Gene Symbol: APOB
APOB
0.030 Biomarker group LHGDN Association between serum concentration of apolipoproteins A-I and B with gallbladder disease. 14567398 2004
Entrez Id: 348
Gene Symbol: APOE
APOE
0.020 GeneticVariation group BEFREE Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. 10613722 2000
Entrez Id: 348
Gene Symbol: APOE
APOE
0.020 GeneticVariation group BEFREE These results suggest that independent of traditional risk factors, apoE genotype may influence gallbladder disease risk, particularly in whites. 16882462 2006
Entrez Id: 1822
Gene Symbol: ATN1
ATN1
0.020 Biomarker group BEFREE Histologically, NOD.ABD biliary disease is indistinguishable from that in NOD.c3c4 mice. 21169553 2011
Entrez Id: 1822
Gene Symbol: ATN1
ATN1
0.020 Biomarker group BEFREE NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. 16636131 2006
Entrez Id: 885
Gene Symbol: CCK
CCK
0.030 Biomarker group BEFREE Despite the increasing use of fatty meal (FM) as a substitute for cholecystokinin (CCK) in pain reproduction during hepato-imino-diacetic acid (HIDA) scan in functional gallbladder disorder, there are no studies comparing the differences between CCK and FM. 28381385 2017
Entrez Id: 885
Gene Symbol: CCK
CCK
0.030 GeneticVariation group BEFREE The integrity of the cholecystokinin receptor gene in gallbladder disease and obesity. 7489984 1995
Entrez Id: 885
Gene Symbol: CCK
CCK
0.030 Biomarker group BEFREE To determine if use of the oral cholecystagogue, Ensure Plus (EP), in hepatobiliary scintigraphy (HBS) leads to a similar distribution of normal and abnormal gallbladder ejection fractions (GBEFs) versus other historical secondary findings of chronic biliary disease in a similar patient population compared with the conventional cholecystokinin analog, sincalide. 31789906 2020
Entrez Id: 907
Gene Symbol: CCT
CCT
0.010 GeneticVariation group BEFREE This study analyzed intrahepatic bile, bile duct tissue, and gallstones from 43 patients with hepatobiliary disease (PTCS group), gallbladder bile and tissue from 23 patients with gallbladder disease (CCT group), and eight patients without hepatobiliary disease (control group). 10961722 2000
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.010 PosttranslationalModification group BEFREE This study demonstrates: (a) a high frequency and specificity of INK4a/ARF methylation in malignant biliary disease compared with mere cholangitis; and (b) the capability to detect these alterations reliably in endoscopically obtained bile. 12738733 2003
Entrez Id: 1036
Gene Symbol: CDO1
CDO1
0.010 PosttranslationalModification group BEFREE CDO1 DNA methylation was quantified using quantitative TaqMan methylation specific PCR (Q-MSP) in 99 primary GBC patients together with the 78 corresponding non-tumor tissues and 26 benign gallbladder disease (including 7 patients with xanthogranulomatous cholecystitis) who underwent surgical resection between 1986 and 2014. 29161283 2017
Entrez Id: 1071
Gene Symbol: CETP
CETP
0.010 Biomarker group BEFREE Restriction fragment length polymorphisms (RFLPs) of apolipoprotein B (XbaI, EcoRI), apolipoprotein A-I (PstI, MspI), and cholesteryl ester transfer protein (CETP) (EcoNI, TaqIA, TaqIB) genes were examined in a series of 210 cholecystectomy patients operated on for symptomatic gallbladder disease and in 92 healthy controls. 7616125 1995
Entrez Id: 3627
Gene Symbol: CXCL10
CXCL10
0.010 AlteredExpression group BEFREE Serum CXCL10, CXCL11 and CXCL12 levels were elevated in all the studied groups except biliary diseases for CXCL11. 29880273 2018
Entrez Id: 6373
Gene Symbol: CXCL11
CXCL11
0.010 Biomarker group BEFREE Serum CXCL10, CXCL11 and CXCL12 levels were elevated in all the studied groups except biliary diseases for CXCL11. 29880273 2018
Entrez Id: 6387
Gene Symbol: CXCL12
CXCL12
0.010 AlteredExpression group BEFREE Serum CXCL10, CXCL11 and CXCL12 levels were elevated in all the studied groups except biliary diseases for CXCL11. 29880273 2018
Entrez Id: 1586
Gene Symbol: CYP17A1
CYP17A1
0.010 GeneticVariation group BEFREE In view of reports linking the CYP17 MspA1 polymorphism to high circulating levels of estrogens and a predisposition to other hormonally related cancers, we examined the relationship between CYP17 MspA1 variants and risk of biliary disease in a population-based case-control study in Shanghai. 16381022 2006
Entrez Id: 9166
Gene Symbol: EBAG9
EBAG9
0.010 AlteredExpression group BEFREE Here we examined RCAS1 expression in biliary diseases. 12044529 2002